MSN Money & Lindsay Rosenwald
In an online article that was posted on the MSN Money page, in the Investing section, Michael Brush describes the best way to achieve success with your investing. In 4 Picks From All-Star Insiders, Michael tells his readers about how the best way for an individual investor, such as Lindsay Rosenwald, to make money in the market is to find, follow, and mimic the most successful insiders. He also states that some insiders are better than others at knowing how to successfully navigate within the stock market game. He then goes on to name some of the top players who have some of the best stats and success in generating dollars from their investing activities.
Among the people he names as a big winner, he presents Dr. Lindsay Rosenwald as the absolute best of them all. Dr. Rosenwald has made large sums of money while operating as a hedge fund manager and venture capitalist who is based in New York. Michael Brush is quick to tell of how Lindsay Rosenwald was able to amass large profits ranging from 100% to 280%. This was done over done over the course of a six month period, after the well timed purchase of two biotech companies named Cell Therapeutics and Neose Technologies. In addition to that the average gain for each trade he made in the stocks of these two companies is 59% for Cell Therapeutics and 64% for Neose Technologies.
As stated by Michael Brush in this article, Lindsay Rosenwald has developed a great reputation as a person who really knows how to spot a winning trade. Lon Gerber, who happens to be an insider expert for Thomson Financial, says that Dr. Rosenwald’s returns are incredible. Furthermore, as far as the consistency of his success, Lindsay Rosenwald has managed to create a broad record of creating successful bio-tech investments over the course of several years.
New York Times Article
In the online article titled BUSINESS PEOPLE; D.H. Blair Picks Doctor As Director of Finance, Daniel F. Cuff of The New York Times describes Dr. Lindsay Rosenwald as one of the few exceptions to the Wall Street truisms which states that doctors tend to make for bad investors. This is made evident with his appointment as managing director in corporate finance for a Wall Street firm named D.H. Blair & Company.
The article then goes on to tell about Dr. Rosenwald’s earlier life and past history. Lindsay Rosenwald, who is originally a native of Philadelphia, was very conflicted as to what career he should choose. He had already finished college and attained a degree in Finance from Penn State, but he also had a strong interest in the medical field and desired to practice as a doctor. This is the reason why he soon chose to enroll in Temple University’s school of medicine.
Even during the time of his medical training and practice, he still made use of his financial knowledge and skills by managing money for his professors and various physicians. He also did some consultation work for health-care companies. Finally, even after having establishing his own medical practice, Dr. Rosenwald decided to give in to the call of Wall Street that was again urging him to pursue work in the financial world.
Daniel F. Cuff then explains how Lindsay Rosenwald combined his knowledge of finance and medicine in order to gain a unique edge when dealing with financial markets. Dr. Rosenwald went to New York in order to work as a securities analyst. Eventually, he got married and started a family, settling down in Manhattan. He also began spending his time looking for and investing in start-up biotech companies that have the potential to make money. The companies he has worked with include names such as Molecular Biosystems, Organogenesis and Marrow Tech.
Cougar Biotech Blog
Cougar Biotech – Wow! is an article that was written by David Feldman and deals with a topic related to finance. Specifically, it talks about a man named Dr. Lindsay Rosenwald and the company named Cougar Biotechnology. David Feldman starts out by highlighting the successful selling of Cougar Biotechnology to Johnson & Johnson for an offer of $1 billion. He also notes that Cougar Biotechnology is backed by none other than Dr. Lindsay Rosenwald himself. David also tells of how Cougar Biotechnology reverse merged with a Form 10 shell that was affiliated by Richard Rappaport’s WestPark Capital in LA, back in 2006.
David Feldman says that the stock price of Cougar Biotechnology rose by 145% since the time when it began to trade after the very beneficial reverse merger. The pre-arranged financing of Cougar Biotechnology was set at an incredibly high dollar amount for its time and even for now today. This totaled 50 million and took place during the time of the reverse merger. The article goes on to state that this reverse merger of a company backed by Dr. Rosenwald can be put on the list of the most successful reverse mergers ever. He also compares the success of the merger to others such as Texas Instruments, Blockbuster Entertainment, Berkshire Hathaway, Occidental Petroleum, Tandy Corp. (Radio Shack), and Turner Broadcasting just to name a few.
Below this article, a comment from a reader, made on February 7, 2010, goes on to explain some of the other accomplishments of Dr. Lindsay Rosenwald. Namely, stating how his various contributions to the world of medical research and the biomedicine field has been of a huge benefit to many. Jake Wilson then states that Dr. Rosenwald’s contributions mainly originate from the group of companies for which the doctor himself is the Founder and Chairman. After that there is mention of how the companies are actively involved in things such as facilitating and coordinating research, corporate development, global investing and development, and the support of biotech companies that are new to the arena business.
Temple Times & Lindsay Rosenwald
Giselle Zayon has created a rather informative article for the online edition of Temple Times. The title of that article is Dual degree helps Medical School graduates take on business world and it speaks about how Dr. Lindsay Rosenwald, a trained medical doctor as well as a financial guru, has combined both his knowledge and unique talents in order to operate as a strong force in the financial world. Giselle describes Lindsay Rosenwald as definitely being the person you want to see if you wish to learn more about biotechnologies and emerging drugs, even if the doctor no longer chooses to practice as a medical physician.
Dr. Rosenwald seems to be a man that was born to make money and be a key player in the financial world. In the article, Giselle Zayon goes on to quote Dr. Lindsay Rosenwald telling of how he manages investor assets, works with private equity, both offshore and domestic hedge funds, invests in both public and private turnaround and start-up companies, and makes placement offerings for certain biotech companies.
The doctor originally studied and attained a degree for finance and economics at Penn State University before taking up medical studies at Temple. A short time after also completing his medical school training, internship, and even establishing his own practice, Lindsay Rosenwald decided to return to the world of finances.
Related posts:
Edison Schouweiler
May 31, 2010 at 1:34 am
Hi,just found your Blog when i google something and wonder what webhosting do you use for your website,the speed is more faster than my web site, i really want to know it.will back to check it out,many thanks!